Content

Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients.

Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients.

Tiedje V, Ting S, Walter RF, Herold T, Worm K, Badziong J, Zwanziger D, Kurt Werner S, Führer D: Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients. Eur J Endocrinol. 2016 Sep;175(3):173-80. doi: 10.1530/EJE-16-0252